Searched for
NATCO OFFICIAL
Hyderabad-based Natco Pharma wants to make Eli Lilly’s Covid drugNatco has sought nod for the manufacture and marketing of baricitinib bulk drug and tablets in 1 to 4 mg versions in India. This move may t...- Natco launches cut price versions of cancer drug ibrutinib in indiaThe patent for the drug is held by Pharmacyclics for three to four more years in India. Pharmacyclics was globally acquired by US giant Abb...
- Natco Pharma gets green nod for Rs 480 crore expansion projectNatco Pharma has received environment clearance (EC) for its Rs 480 crore expansion project in Telangana that would generate 1,500 jobs.
- US court finds Teva's Copaxone patent invalid again: Natco PharmaNatco Pharma, a city-based drug maker, today said the US Court of Appeals for Federal Court has again found one of the patents of Teva's Co...
- Cipla, Mylan in race to buy select brands of Sun Pharma put up for saleThe total value of the seven drugs is estimated to be close to Rs 137 crore according to data available with AIOCDA.
- Setback to Natco pharma; US Supreme Court sends Teva patent case to Federal CircuitThe US Supreme Court has sent back the patent case related to Teva's multiple sclerosis drug Copaxone for a review by the Federal Circuit.
- Aurobindo, Glenmark, Natco get USFDA nod for migraine tabletsNatco said the drug shipments were already made and the product is being marketed by its partner Breckenridge Pharmaceuticals in the US mar...
- Intellectual Property Appellate Board postpones Bayer's compulsory licence appealIPAB has postponed German company Bayer AG's appeal against the grant of a compulsory licence of its patented drug Nexavar to Natco Pharma ...
- Delhi High Court gives Natco Pharma a week to respond to Bristol-Myers Squibb contempt chargesDelhi HC has given Natco Pharma a week's time to respond to the contempt charges slapped by American firm Bristol-Myers Squibb (BMS).
- Natco Pharma, Bristol-Myers Squibb face off in Court over sale of dasatinib cloneHyderabad-based Natco says it has not reneged on its undertaking as its version of the drug is different and does not infringe upon the pat...
- Natco Pharma begins sales of Bristol Myers' cancer drug DasatinibHyderabad-based generic drugmaker Natco Pharma has started selling copies of global pharma major Bristol Myers Squibb's cancer drug Dasatin...
- Natco, Mylan to appeal against New York district court verdictThe decision by the US court covers several patents for the chemical composition of Copaxone, methods of using the product and processes fo...
- Natco seeks Pfizer nod for drug cloneIndian Pharma Co claims it can sell HIV drug at one-fifth the price.
- Natco Pharma open to settle cancer drug patent case with US coNatco Pharma Ltd on Friday did not rule out a settlement over the patent issue with Celgene Corp, which has said it would file a complaint ...
- Natco to launch cancer drug as min stays DCGI orderThe original maker of the drug, American firm Abraxis Bioscience had complained about the side effects of Natco’s version of the medicine.
- Natco Pharma faces criminal actionThe country’s top drug regulator plans to initiate criminal proceedings against Hyderabad-based Natco Pharma for selling “substandard” brea...
- Govt may cap retail price of swine flu drugThe government may cap the retail price of anti-viral drug oseltamivir used for the treatment of swine flu if market competition does not f...
- Govt orders recall as Natco cancer drug fails toxin testThe drug regulator (DCGI) acted afer the US firm filed a written complaint citing serious side-effects that the generic may cause.
- Natco plans copy of Roche cancer drugSome more good news could be around the corner for cancer patients and healthcare groups campaigning for access to cheaper medicines. A sec...
- Natco Pharma to spend $20-25 mn on US retail buysNatco Pharma Ltd will spend $20 million-$25 million to acquire drug retail chains in the United States and expects to close some deals by D...
Load More
